Robu S - Search Results

1

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04.

Varasteh Z, Mohanta S, Robu S, Braeuer M, Li Y, Omidvari N, Topping G, Sun T, Nekolla SG, Richter A, Weber C, Habenicht A, Haberkorn UA, Weber WA. Varasteh Z, et al. Among authors: robu s. J Nucl Med. 2019 Dec;60(12):1743-1749. doi: 10.2967/jnumed.119.226993. Epub 2019 Aug 12. J Nucl Med. 2019. PMID: 31405922 Free PMC article.

2

Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression.

Robu S, Richter A, Gosmann D, Seidl C, Leung D, Hayes W, Cohen D, Morin P, Donnelly DJ, Lipovšek D, Bonacorsi SJ, Smith A, Steiger K, Aulehner C, Krackhardt AM, Weber WA. Robu S, et al. J Nucl Med. 2021 Sep 1;62(9):1228-1234. doi: 10.2967/jnumed.120.258384. Epub 2021 Jan 30. J Nucl Med. 2021. PMID: 33517324 Free PMC article.

3

Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using ⁶⁸Ga-FAPI-04.

Notohamiprodjo S, Nekolla SG, Robu S, Villagran Asiares A, Kupatt C, Ibrahim T, Laugwitz KL, Makowski MR, Schwaiger M, Weber WA, Varasteh Z. Notohamiprodjo S, et al. Among authors: robu s. J Nucl Cardiol. 2022 Oct;29(5):2254-2261. doi: 10.1007/s12350-021-02603-z. Epub 2021 Apr 15. J Nucl Cardiol. 2022. PMID: 33860458 Free PMC article.

4

First In-Human Medical Imaging with a PASylated ⁸⁹Zr-Labeled Anti-HER2 Fab-Fragment in a Patient with Metastatic Breast Cancer.

Richter A, Knorr K, Schlapschy M, Robu S, Morath V, Mendler C, Yen HY, Steiger K, Kiechle M, Weber W, Skerra A, Schwaiger M. Richter A, et al. Among authors: robu s. Nucl Med Mol Imaging. 2020 Apr;54(2):114-119. doi: 10.1007/s13139-020-00638-7. Epub 2020 Apr 20. Nucl Med Mol Imaging. 2020. PMID: 32377263 Free PMC article.

5

Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.

Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, Wester HJ. Robu S, et al. J Nucl Med. 2017 Feb;58(2):235-242. doi: 10.2967/jnumed.116.178939. Epub 2016 Sep 15. J Nucl Med. 2017. PMID: 27635024 Free article.

6

Automated synthesis of [¹⁸F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions.

Wurzer A, Di Carlo D, Herz M, Richter A, Robu S, Schirrmacher R, Mascarin A, Weber W, Eiber M, Schwaiger M, Wester HJ. Wurzer A, et al. Among authors: robu s. EJNMMI Radiopharm Chem. 2021 Jan 23;6(1):4. doi: 10.1186/s41181-021-00120-5. EJNMMI Radiopharm Chem. 2021. PMID: 33484364 Free PMC article.

7

Radiosynthesis and pre-clinical evaluation of [⁶⁸Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer.

Chopra S, Singh B, Koul A, Mishra AK, Robu S, Kaur A, Ghai A, Caplash N, Wester HJ. Chopra S, et al. Among authors: robu s. Appl Radiat Isot. 2019 Jul;149:9-21. doi: 10.1016/j.apradiso.2019.04.008. Epub 2019 Apr 10. Appl Radiat Isot. 2019. PMID: 31003040

8

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer.

Horn T, Krönke M, Rauscher I, Haller B, Robu S, Wester HJ, Schottelius M, van Leeuwen FWB, van der Poel HG, Heck M, Gschwend JE, Weber W, Eiber M, Maurer T. Horn T, et al. Among authors: robu s. Eur Urol. 2019 Oct;76(4):517-523. doi: 10.1016/j.eururo.2019.03.045. Epub 2019 Apr 12. Eur Urol. 2019. PMID: 30987843

9

Synthesis and preclinical evaluation of novel ¹⁸F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with ¹⁸F-DCFPyl and ¹⁸F-PSMA-1007.

Robu S, Schmidt A, Eiber M, Schottelius M, Günther T, Hooshyar Yousefi B, Schwaiger M, Wester HJ. Robu S, et al. EJNMMI Res. 2018 Apr 12;8(1):30. doi: 10.1186/s13550-018-0382-8. EJNMMI Res. 2018. PMID: 29651565 Free PMC article.

10

^99mTechnetium-based Prostate-specific Membrane Antigen-radioguided Surgery in Recurrent Prostate Cancer.

Maurer T, Robu S, Schottelius M, Schwamborn K, Rauscher I, van den Berg NS, van Leeuwen FWB, Haller B, Horn T, Heck MM, Gschwend JE, Schwaiger M, Wester HJ, Eiber M. Maurer T, et al. Among authors: robu s. Eur Urol. 2019 Apr;75(4):659-666. doi: 10.1016/j.eururo.2018.03.013. Epub 2018 Apr 4. Eur Urol. 2019. PMID: 29625755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters